Israel's Future Medicine Revolution: IATI MIXiii Health-Tech.IL Conference in Jerusalem - Bigger and More Comprehensive
Israel's Future Medicine Revolution: IATI MIXiii Health-Tech.IL Conference in Jerusalem - Bigger and More Comprehensive
In an era where technology is reshaping the future of global medicine - from revolutionary genetic treatments to AI-based drug development - Israel is establishing itself as a leading innovation hub. Accordingly, hundreds of experts, investors, and leading entrepreneurs from around the world will gather in Jerusalem for the IATI MIXiii Health-Tech.IL 2025 conference, taking place on March 4-5 at the Jerusalem International Convention Center
During a period of unprecedented growth in the medtech market, with accelerated growth in personalized medicine, cell therapies, and innovative drugs, the conference aims to establish Israel at the forefront of global innovation. The annual event of the Israel Advanced Technology Industries (IATI) will showcase how leading Israeli companies are making significant breakthroughs - from AI systems for rare disease detection, innovative drugs and treatments, to advanced technologies for drug development, rehabilitation, and more.
"The Israeli industry continues to surprise and innovate even in challenging times," emphasizes Karin Meir Rubinstein, CEO and President of IATI. "This year we will host leading investors from Silicon Valley, Europe, and the Far East, who come to see how Israel turns challenges into opportunities and leads the next revolution in the medical world."
Among the conference's leading participants: Dr. Stefan Oschmann, former Chairman and CEO of Merck; Dr. Jeremy Levin, CEO of OVID and former CEO of Teva; Prof. Eli Sprecher, Director of the Tel Aviv Sourasky Medical Center; Dr. Peter Cash, Chairman of Camelot Bio Capital; Professor Yoram Weiss, CEO of Hadassah Medical Center; Mr. Dror Bin, CEO of the Innovation Authority; Mr. Oded Spindel, Vice President of HCW Investment Bank; Mr. Lior Bonfis, President of Philips Israel; Mori Arkin, Founder and Chairman of Arkin Holdings; Mr. Moshe Lion, Mayor of Jerusalem; Dr. Giora Yaron, former Chairman of Itamar Medical, and others.
1 View gallery
IATI MIXiii Health-Tech.IL Conference in Jerusalem - Bigger and More Comprehensive
(Photo: Constantin Grossman)
Yaakov Michlin, Conference Chairman and CEO of Bio-Light, reported that this year several conferences and activities have been merged and will include fascinating sessions including: leading technologies in physical and mental rehabilitation in collaboration with the Innovation Authority, digital health startup competition together with EY, breakthrough developments in pharmaceuticals in partnership with Teva, advanced solutions for cancer diagnosis and treatment, leading academic research in collaboration with the Weizmann Institute and Hebrew University, OIS Israel - innovation in eye diseases, AI applications in drug research, and more.
The conference will focus on the fascinating intersection between medical technology, engineering, and digital technologies - a combination that leads to a revolution in treating complex diseases and drug development. Simultaneously, hundreds of business meetings between Israeli entrepreneurs and international investors will take place through an innovative meeting system. The conference will also include a gala evening event and special tours in Jerusalem, and for the first time in Israel, will offer heavily discounted entry for international venture capital investors and enable virtual exposure to hundreds of investors and participants from abroad.
The event, which is the leading one of its kind in the Middle East, receives broad support from the government and industry, including relevant government ministries, the Innovation Authority, the Jerusalem Development Authority, Ministry of Economy, Ministry of Foreign Affairs, Ministry of Science, Foreign Trade Administration, Export Institute, Growth Administration, Employers' Administration, and more.
